NMR spectroscopic and theoretical chemistry studies on the internal acyl migration reactions of the 1-O-acyl-β-D-glucopyranuronate conjugates of 2-, 3-, and 4-(trifluoromethyl)benzoic acids

Chemical Research in Toxicology

Volumn 9, Issue 8, 1996, Pages 1414-1424

  Nicholls, Andrew W ^a   Akira, Kazuki ^a,d   Lindon, John C ^a   Duncan Farrant, R ^b   Wilson, Ian D ^c   Harding, John ^c   Killick, David A ^c   Nicholson, Jeremy K ^a  

^a UNIVERSITY OF LONDON   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

^c ASTRAZENECA   (United Kingdom)

^d TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOXYLIC ACID; GLUCURONIDE; HYDROXIDE; NONSTEROID ANTIINFLAMMATORY AGENT;

ACYLATION; ARTICLE; CALCULATION; CHEMICAL ANALYSIS; CONJUGATION; ENZYME ACTIVITY; HYDROLYSIS; MIGRATION; NUCLEAR MAGNETIC RESONANCE; PHYSICAL CHEMISTRY;

ACYLATION; BENZOATES; BUFFERS; CHEMISTRY, PHYSICAL; GLUCURONATES; HALF-LIFE; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR CONFORMATION; POLYSACCHARIDES; PROTEIN BINDING; SPECTROMETRY, MASS, FAST ATOM BOMBARDMENT;

EID: 0029851431     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx960047r     Document Type: Article

References (52)

1. Dutton, G. J. (1980) Glucuronidation of drugs and other compounds, CRC Press, Boca Raton, FL.
2. Fenselau, C. (1994) Acyl Glucuronides as chemically reactive intermediates. In Conjugation-deconjugation reactions in drug metabolism and toxicity (Kauffman, F. C., Ed.) pp 367-389, Springer-Verlag, Berlin.
3. Spahn-Langguth, H., and Benet, L. Z. (1992) Acyl glucuronides revisited: Is the glucuronidation process a toxification as well as a detoxification mechanism. Drug Metab. Rev. 24 (1), 5-48.
4. Hyneck, M. L., Smith, P. C., Munafo, A., McDonagh, A. F., and Benet, L. Z. (1988) Disposition and irreversible plasma protein binding of tolmetin in humans. Clin. Pharmacol. Ther. 44, 107-114.
5. Dickinson, R. G., Hooper, W. D., and Eadie, M. J. (1984) pH-dependent rearrangement of the biosynthetic ester glucuronide of valproic acid to β-glucuronidase-resistant forms. Drug. Metab. Dispos. 12, 247-252.
6. King, A. R., and Dickinson, R. G. (1991) Studies on the reactivity of acyl glucuronides-I. Phenolic glucuronidiation of isomers of diflunisal acyl glucuronide in the rat. Biochem. Pharmacol. 42, 2289-2299.
7. α glucuronide in cholestasis and during storage in vitro. Intramolecular rearrangement to positional isomers of glucuronic acid. Biochem. J. 171, 203-214.
8. Haines, A. H. (1976) Relative reactivities of hydroxyl groups in carbohydrates. Adv. Carbohydr. Chem. Biochem. 33, 11-109.
9. 9-11-carboxytetrahydrocannabinol glucuronide. Chem. Res. Toxicol. 2, 316-324.
10. Fischer, E. (1920) Migration of the acyl in glycerides. Chem. Ber. 53, 1621-1633.
11. Angyal, S. J., and Melrose, G. J. H. (1965) Cyclitols. XVIII. Acetyl migration equilibrium between axial and equatorial acetates. J. Chem. Soc., 6494-6500.
12. Sidelmann, U. G., Gavaghan, C., Carless, H. A. J., Farrant, R. D., Lindon, J. C., Wilson, I. D., and Nicholson, J. K. (1995) Identification of the positional isomers of 2-fluorobenzoic acid 1-O-acyl glucuronide by directly coupled HPLC-NMR. Anal. Chem. 67, 3401-3404.
13. 1H HPLC-NMR analysis of mixtures of isomeric ester glucuronide conjugates of (trifluoromethyl)benzoic acids. J. Chromatogr. 728, 377-385.
14. Smith, P. C., Song, W. Q., and Rodriguez, R. J. (1992) Covalent binding of etodolac acyl glucuronide to albumin in vitro. Drug Metab. Dispos. 20, 962-965.
15. Rachmel, A., Hazelton, G. A., Yergey, A. L., and Liberate, D. J. (1985)Furosemide 1-O-acyl glucuronide. In vitro biosynthesis and pH-dependent isomerization to β-glucuronidase-resistant forms. Drug Metab. Dispos. 13, 705-710.
16. Ruelius, H. W., Young, E. M., Kirkman, S. K., Schillings, R. T., Sisenwine, S. F., and Janssen, F. W. (1985) Biological fate of acyl glucuronides in the rat. The role of rearrangement, intestinal enzymes and reabsorption. Biochem. Pharmacol. 34, 451-452.
17. Volland, C., Sun, H., Dammeyer, J., and Benet, L. Z. (1991) Stereoselective degradation of fenoprofen acyl glucuronide enantiomers and irreversible binding to plasma protein. Drug Metab. Dispos. 19, 1080-1086.
18. Watt, J. A., and Dickinson, R. G. (1990) Reactivity of diflunisal acyl glucuronide in human and rat plasma and albumin solutions. Biochem. Pharmacol. 39, 1067-1075.
19. Smith, P. C., McDonagh, A. F., and Benet, L. Z. (1986) Irreversible binding of zomepirac to plasma protein in vitro and in vivo. J. Clin. Invest. 77, 934-939.
20. Zia-Amirhosseini, P., Harris, R. Z., Brodsky, F. M., and Benet, L. Z. (1995) Hypersensitivity to nonsteroidal anti-inflammatory drugs. Nat. Med. 1, 2-4.
21. McKinnon, G. E., and Dickinson, R. G. (1989) Covalent binding of diflunisal and probenecid to plasma protein in humans: persistence of the adduets in the circulation. Res. Commun. Chem. Pathol. Pharmacol. 66, 339-354.
22. Worral, S., and Dickinson, R. G. (1995) Rat serum albumin modified by diflunisal acyl glucuronide is immunogenic in rats. Life Sci. 56, 1921-1930.
23. Pohl, L. R., Satoh, H., Christ, D. D., and Kenna, J. G. (1988) The immunologic and metabolic basis of drug hypersensitivities. Annu. Rev. Pharmacol. 28, 367-387.
24. Van Breeman, R. B., and Fenselau, C. (1985) Acylation of albumin by 1-O-acyl glucuronides. Drug Metab. Dispos. 13, 318-320.
25. Ruelius, H. W., Kirkman, S. K., Young, E. M., and Janssen, F. W. (1986) Reactions of oxaprozin-1-O-acyl glucuronide in solutions of human plasma and albumin. Adv. Exp. Med. Biol. 197, 431-441.
26. Smith, P. C., Benet, L. Z., and Modonagh, A. F. (1990) Covalent binding of zomepirac glucuronide to proteins: evidence for a Schiff base mechanism. Drug Metab. Dispos. 18, 639-644.
27. Scheline, R. R. (1968) Drug metabolism by intestinal microorganisms. J. Pharm. Sci. 57, 2021-2037.
28. Mulder, G. J. (1987) The interrelationship between different conjugating enzymes in vivo. In Drug metabolism from molecule to man (Benford, D. J., Bridges, J. W., and Gibson, G. G., Eds.) pp 121-134, Taylor and Francis, London.
29. Benet, L. Z., Spahn-Langguth, H. S., Iwakawa, S., Volland, C., Mizuma, T., Mayer, S., Mutschier, E., and Lin, E. T. (1993) Predictability of the covalent binding of acidic drugs in man. Life Sci. 53, 141-146.
30. Ghauri, F. Y. K., Blackledge, C. A., Glen, R. C., Sweatman, B. C., Lindon, J. C., Beddell, C. R., Wilson, I. D., and Nicholson, J. K. (1992) Quantitative structure-metabolism relationships for substituted benzoic acids in the rat, Computational chemistry, NMR spectroscopy and pattern recognition studies. Biochem. Pharmacol. 44, 1935-1946.
31. Ghauri, F. Y. K., Blackledge, C. A., Glen, R. C., Sweatman, B. C., Lindon, J. C., Beddell, C. R., Wilson, I. D., and Nicholson, J. K. (1992) An approach to a metabolic expert system: structure-metabolism relationships for benzoic acids in the rat. Methodol. Surv. Biochem. Anal. 22, 21-28.
32. 1H-NMR studies of the metabolism of 4-(trifluoromethyl)-benzoic acid in the rat. Methodol. Surv. Biochem. Anal. 20, 321-324.
33. 1H-NMR spectroscopy. J. Pharm. Biomed. Anal. 8, 939-944.
34. Schmidt, R. R., and Grundler, G. (1981) Simple synthesis of β-D-glucopyranosyluronates. Synthesis 1981, 885-887.
35. (1995) Spartan User's Guide. Version 4.0, Wavefunction Inc., Irvine.
36. 19F NMR spectroscopy and computational chemistry to structure metabolism relationships. Xenobiotica 25, 1269-1281.
37. Cupid, B. C., Beddell, C. R., Lindon, J. C., and Nicholson, J. K. (1996) Quantitative structure metabolism relationships for substituted benzoic acids in the rabbit: Computational chemistry and pattern recognition studies. Xenobiotica 26, 157-176.
38. Fletcher, R. (1987) Practical methods of optimization, pp 44-79, John Wiley and Sons, Chichester.
39. Klamt, A., and Schuurmann, G. (1993) COSMO: A new approach to dielectric screening in solvents with explicit expressions for the screening energy and its gradient. J. Chem. Soc., Perkin Trans. 2 5, 799-805.
40. Fukui, K., Yonezawa, T., Nagata, C., and Shingu, H. (1954) Molecular-orbital theory of orientation in aromatic, heteroaromatic and other conjugated molecules. J. Chem. Phys. 22, 1433-1442.
41. Janssen, F. W., Kirkman, S. K., Fenselau, C., Stogniew, M., Hofmann, B. R., Young, E. M., and Ruelius, H. W. (1982) Metabolic formation of N- and O-glucuronides of 3-(p-chlorophenyl)thiazolo[3,2-a]benzimidazole-2-acetic acid. Rearrangement of the 1-O-acyl glucuronide. Drug Metab. Dispos. 10, 599-604.
42. Hansen-Moller, J., Cornett, C., Dalgaard, L., and Hansen, S. H. (1988) Isolation and identification of the rearrangement products of diflunisal 1-O-acyl glucuronide. J. Pharm. Biomed. Anal. 6, 229-240.
43. Lindon, J. C., and Ferrige, A. G. (1980) Digitization and data processing in Fourier transform NMR. Prog. NMR Spectrosc. 14, 27-66.
44. (1972) Chemical kinetics. Volume 10. Ester formation and hydrolysis and related reactions, Elsevier Publishing Co., London.
45. Logan, S. R. (1996) Fundamentals of Chemical Kinetics, Longman, Harlow, England.
46. Sidelmann, U. G., Hansen, S. H., Gavaghan, C., Carless, H. A. J., Farrant, R. D., Lindon, J. C., Wilson, I. D., and Nicholson, J. K. (1996) Measurement of the internal acyl migration reaction kinetics using directly coupled HPLC-NMR: Application for positional isomers of synthetic (2-fluorobenzoyl)-D-glucopyranuronic acid. Anal. Chem. 68, 2564-2572.
47. Stewart, J. J. P. (1989) Optimization of parameters for semiempirical methods. II. Applications. J. Comput. Chem. 10, 221-264.
48. Bondi, A. (1964) Van der Waals volumes and radii. J. Phys. Chem. 68, 441.
49. Smith, P. C., and Benet, L. Z. (1986) Characterization of the isomeric esters of Zomepirac glucuronide by proton NMR. Drug Metab. Dispos. 14, 503-505.
50. Malet-Martino, M. C., and Martine, R. (1989) The application of nuclear magnetic resonance spectroscopy to drug metabolism studies. Xenobiotica 19, 583-607.
51. Hehre, W. J. (1995) Practical strategies for electronic structure calculations, Wavefunction Inc., Irvine.
52. Faed, E. M. (1984) Properties of acyl glucuronides: Implications for studies of the pharmacokinetics and metabolism of acidic drugs. Drug Metab. Rev. 15, 1213-1249.